Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Recombinant human aspartylglucosaminidase

EU orphan designation number: EU/3/14/1410   
Active ingredient: Recombinant human aspartylglucosaminidase
Indication: Treatment of aspartylglucosaminuria
Sponsor: Chiesi Farmaceutici S.p.A.
Via Palermo 26/A, 43122 Parma, Italia

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
19/01/2015 Orphan designation EMA/OD/172/14 (2015)174 of 15/01/2015
27/07/2018 Transfer of orphan designation EMA/OD/172/14/T/01 (2018)5051 of 25/07/2018